To advance medical technology and achieve precision health, ASUS today formed a strategic alliance with the National Health Research Institutes (NHRI) and NVIDIA to launch the "AI Biomedical Information Innovation Research and Application Service Center" project. This collaboration combines medical and health research data, AI cloud technology, and high-speed computing servers to create Taiwan's first dedicated AI supercomputer for biomedicine. In addition to providing ultra-high-speed computing for national-level tasks such as precision health, vaccine development, and new drug research, ASUS is also collaborating with AI experts and the NHRI to further develop health big data and biomedical AI models, accelerating the application of AI in Taiwan's biomedical industry.
ASUS Chairman Jonney Shih attended the cooperation ceremony and said, "ASUS is delighted to collaborate with NVIDIA to build Taiwan's first AI supercomputer for biomedicine, leveraging our years of accumulated AI cloud core technologies. This will contribute to Taiwan's upcoming national-level missions such as vaccine development and new drug discovery. We also look forward to working with the National Health Research Institutes in the future to accelerate digital innovation in Taiwan's biotechnology industry."
In this collaboration, ASUS provided the AIHPC cloud platform developed by its Cloud Architecture Software Center (OCIS), maintenance and consulting services and training for the Taiwan Smart Cloud Service (TWS), and implemented a comprehensive plan including multi-body big data analysis software, medical image recognition software, and drug/vaccine development software. Together with the National Health Research Institutes (NHRI), they formed a research team to overcome technical obstacles and successfully develop the AI model. This collaboration helps the NHRI enhance its core AI capabilities and expand the service capacity of the National Biomedical Think Tank. Looking ahead, the biomedical AI supercomputer will work with academic, research, and medical institutions and industry to develop innovations and applications in diverse biomedical fields, connecting with the international community and deepening the global visibility of Taiwan's medical technology.